Directorate change confirmation

Summary by AI BETAClose X

One Health Group plc announces that Shantanu Shahane has retired as Chief Medical Officer and stepped down from the Board, though he will continue in clinical practice, with Professor Anil Hormis assuming the role of Medical Director from October 1, 2026, following a transition period.

Disclaimer*

One Health Group PLC
09 October 2026
 

One Health Group plc

("One Health", the "Company" or the “Group”)

 

Directorate change confirmation

 

One Health Group plc (AIM: OHGR), the independent provider of NHS-funded surgical procedures for patients referred from the NHS through ‘Patient Choice’, confirms that further to the 1 April 2026 announcement Shantanu Shahane has now retired from the role of Chief Medical Officer and stepped down from the Board, however, he will continue in clinical practice within One Health Group.

 

To ensure a seamless transition, Shantanu has worked closely with Prof Anil Hormis since his appointment in April 2026. Anil has played an integral part in One Health’s clinical governance arrangements, being actively involved in clinical oversight and quality assurance activities since joining the Group. This transition will ensure continuity of leadership and governance oversight as the Company continues to focus on delivering outstanding patient care. Prof Anil Hormis assumed the position of Medical Director from the 1 October 2026.

 

Anil Hormis

 

Prof. Anil Hormis, Medical Director of One Health

 

Derek Bickerstaff, Chairman, commented:

“On behalf of the Board I would like to express our thanks to Shantanu for his dedication as Medical Director and Chief Medical Officer over many years. I am delighted that we will have his ongoing support within our clinical practice and look forward to working with, Prof Anil Hormis as we continue developing our clinical governance framework, delivering high-quality care to NHS patients.”

 

If you wish to keep up to date on Company news please email: onehealth@walbrookpr.com

 

For more information, please contact:

 

One Health Group plc

Derek Bickerstaff, Chairman

Adam Binns, CEO

 

www.onehealth.co.uk/investors

Via Walbrook PR

Panmure Liberum (Nominated Adviser and Broker)

Emma Earl, Will Goode, Mark Rogers

Rupert Dearden

 

Tel: +44 (0)20 3100 2000

Walbrook PR (Media & Investor Relations)

Alice Woodings, Paul McManus,

Rachel Broad

Tel: +44 (0)20 7933 8780 or onehealth@walbrookpr.com

Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893

                                                                    +44 (0)7747 515 393

 

 

A blurry image of people

AI-generated content may be incorrect.

 

About One Health Group plc (www.onehealth.co.uk)

Last year One Health engaged 88 NHS Consultants (excluding anaesthetists) who sub-specialise in the various surgeries offered by the Company, through a growing network of community-based outreach clinics and surgical operating locations. One Health continues to deliver strong growth and, in the year, to March 2026 provided much needed care to almost 19,000 new patients, through over 50,000 consultations and over 8,000 surgical procedures. One Health deploys surgeons and anaesthetists that are mostly employed by the NHS, on a subcontracted basis. It currently works with over 140 professionals across 14 independent hospitals and 40 outreach clinics. Within these community-based outreach clinics all consultations and post-operative physiotherapy is delivered where required, reducing patient inconvenience, excess travel and distress.

 

One Health's activities are focused on areas where NHS patient needs are under-supplied by the local NHS service, population density is relatively high and the level of private medical insurance or the ability to self-fund is relatively low. Currently, the Company's activities are focused in Yorkshire, Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue is derived from 29 ICBs across England as well as contracts with local NHS trusts to transfer their internal waiting list patients to One Health for quicker treatment. One Health's business model has focused to date on four main areas: orthopaedics, spine, general surgery and gynaecology, which represent the majority of the national waiting list, with urology introduced at the end of FY25.

 

Spine and orthopaedics are particularly attractive areas for One Health as the Directors believe that they benefit from powerful growth drivers in terms of an ageing demographic, physical inactivity and an increasing proportion of the population being categorised as obese. Within orthopaedics, the most common surgeries performed by One Health are knee and hip replacements.

 

Online investor presentation

Click below for the latest online presentation by Derek Bickerstaff, Chairman and Adam Binns, Chief Executive Officer, which offers insights into the Company’s financial results for the year ended 31 March 2026, growth strategy and long-term vision: https://www.investormeetcompany.com/meetings/investor-presentation-1068

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings